186 related articles for article (PubMed ID: 16185157)
1. The NF-kappaB signalling pathway: a therapeutic target in lymphoid malignancies?
Stoffel A
Expert Opin Ther Targets; 2005 Oct; 9(5):1045-61. PubMed ID: 16185157
[TBL] [Abstract][Full Text] [Related]
2. NF-κB and the link between inflammation and cancer.
DiDonato JA; Mercurio F; Karin M
Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction.
Grilli M; Memo M
Biochem Pharmacol; 1999 Jan; 57(1):1-7. PubMed ID: 9920279
[TBL] [Abstract][Full Text] [Related]
4. Molecularly-targeted Strategy and NF-κB in lymphoid malignancies.
Horie R
J Clin Exp Hematop; 2013; 53(3):185-95. PubMed ID: 24369220
[TBL] [Abstract][Full Text] [Related]
5. Rel/NF-kappa B/I kappa B signal transduction in the generation and treatment of human cancer.
Gilmore T; Gapuzan ME; Kalaitzidis D; Starczynowski D
Cancer Lett; 2002 Jul; 181(1):1-9. PubMed ID: 12430173
[TBL] [Abstract][Full Text] [Related]
6. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
Wong ET; Tergaonkar V
Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
[TBL] [Abstract][Full Text] [Related]
8. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
[TBL] [Abstract][Full Text] [Related]
9. NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.
Yu L; Li L; Medeiros LJ; Young KH
Blood Rev; 2017 Mar; 31(2):77-92. PubMed ID: 27773462
[TBL] [Abstract][Full Text] [Related]
10. [Noncanonical NF-κB pathway and hematological malignancies].
Wang WJ; Sun AN; Guo F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1069-73. PubMed ID: 20723331
[TBL] [Abstract][Full Text] [Related]
11. The role of NF-kappaB in lymphoid malignancies.
Packham G
Br J Haematol; 2008 Oct; 143(1):3-15. PubMed ID: 18573107
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.
Nagel D; Vincendeau M; Eitelhuber AC; Krappmann D
Oncogene; 2014 Dec; 33(50):5655-65. PubMed ID: 24469030
[TBL] [Abstract][Full Text] [Related]
13. Involvement of NF-κB in mediating the anti-tumour effects of combretastatins in T cells.
Pollock JK; Greene LM; Nathwani SM; Kinsella P; O'Boyle NM; Meegan MJ; Zisterer DM
Invest New Drugs; 2018 Aug; 36(4):523-535. PubMed ID: 29460212
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of NF-κB deregulation in lymphoid malignancies.
Krappmann D; Vincendeau M
Semin Cancer Biol; 2016 Aug; 39():3-14. PubMed ID: 27262792
[TBL] [Abstract][Full Text] [Related]
15. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).
Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL
J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB as a potential molecular target for cancer therapy.
Lee CH; Jeon YT; Kim SH; Song YS
Biofactors; 2007; 29(1):19-35. PubMed ID: 17611291
[TBL] [Abstract][Full Text] [Related]
17. Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?
Verzella D; Fischietti M; Capece D; Vecchiotti D; Del Vecchio F; Cicciarelli G; Mastroiaco V; Tessitore A; Alesse E; Zazzeroni F
Curr Drug Targets; 2016; 17(3):311-20. PubMed ID: 26343112
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB in cancer--a friend turned foe.
Ravi R; Bedi A
Drug Resist Updat; 2004 Feb; 7(1):53-67. PubMed ID: 15072771
[TBL] [Abstract][Full Text] [Related]
19. NF-κB in cancer therapy.
Li F; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
Arch Toxicol; 2015 May; 89(5):711-31. PubMed ID: 25690730
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors.
Turco MC; Romano MF; Petrella A; Bisogni R; Tassone P; Venuta S
Leukemia; 2004 Jan; 18(1):11-7. PubMed ID: 14574329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
